Cargando…

Modular Pelvic Exenteration for Advanced Rectal Cancer in Frozen Pelvis

Patient: Male, 51-year-old Final Diagnosis: Colorectal adenocarcinoma Symptoms: Emaciation • fatigue • dysuria • bloody urine • bloody stool • anal pain Clinical Procedure: — Specialty: Gastroenterology and Hepatology • Oncology • Surgery OBJECTIVE: Unusual clinical course BACKGROUND: Surgery for lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Yan, Zhaopeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660309/
https://www.ncbi.nlm.nih.gov/pubmed/37968899
http://dx.doi.org/10.12659/AJCR.941684
Descripción
Sumario:Patient: Male, 51-year-old Final Diagnosis: Colorectal adenocarcinoma Symptoms: Emaciation • fatigue • dysuria • bloody urine • bloody stool • anal pain Clinical Procedure: — Specialty: Gastroenterology and Hepatology • Oncology • Surgery OBJECTIVE: Unusual clinical course BACKGROUND: Surgery for locally advanced rectal cancer with frozen pelvis is challenging. Therefore, we designed the “modular pelvic exenteration” surgical strategy to achieve better radical resection. CASE REPORT: A 51-year-old man with rectal cancer refused surgery and received chemotherapy and radiotherapy. He was intolerant to chemotherapy and did not respond well to radiotherapy. With cancer progression, he presented at our hospital with emaciation, fatigue, dysuria, bloody urine, bloody stool, and anal pain. Computed tomography and magnetic resonance imaging revealed the rectal tumor involved multiple adjacent organs and caused rectovesical fistula, bilateral hydronephrosis, hydroureterosis, and local pelvic infection. The rectal tumor was fixed in the pelvic cavity, presenting a frozen pelvis pattern. There was no distant metastasis. As the patient could not tolerate chemotherapy, was unsuitable for immune-check point inhibitor because the tumor had microsatellite stability, and did not respond well to radiotherapy, surgical resection seemed the most suitable treatment option. After the patient’s anemia and malnutrition improved, our designed modular pelvic exenteration surgery was performed. In this strategy, we divided pelvic organs and tissues into 4 independent modules. After combining the modules planned to be resected, we delineated the pre-resection margin. By this strategy, the tumor was removed en bloc, with a clear resection margin. The patient was discharged 13 days after the operation, without complications. Follow-up for 24 months revealed no signs of tumor recurrence. CONCLUSIONS: For locally advanced rectal cancer with frozen pelvis, the modular pelvic exenteration strategy may help to achieve satisfactory surgical effects in selected patients.